Shinetsu chemical<4063>: ¥6731 (+¥427)
Significant rise.In the first quarter earnings released last weekend, the operating profit was 191 billion yen, up 0.1% YoY. The market consensus was expected to be slightly less than 170 billion yen, which was an unexpected increase. It is believed that the increase in shipments of wafers was better than expected. The full-year plan is 735 billion yen, a 4.8% decrease from the previous period, and it was announced at this time that it was below the consensus of about 780 billion yen, but it is considered extremely conservative. Rather, in response to the first-quarter settlement, the previous consensus level is expected to be raised.
Keyence<6861>: ¥64810 (-¥1120)
Decline. In the first quarter earnings announcement last weekend, the operating profit was 123.4 billion yen, up 10.9% YoY, and landed at almost the market expected level. The market consensus for the full year expects a profit increase of about 12%, which is also seen as a smooth trend. However, positive surprises are scarce, and it seems to be leading to a trend dominated by a sense of exhaustion, as it is a stock with high expectations for earnings announcements. Despite the improvement in gross profit margin in the first quarter, selling, general, and administrative expenses increased compared to the previous quarter.
Screen<7735>: ¥11870 (-¥865)
Significant decrease. In the first quarter earnings released last weekend, the operating profit was 27.8 billion yen, 2.1 times the same period of the previous year, and is thought to have exceeded the market expectations by about 3 billion yen. Reflected in the upward trend of the first quarter, the full-year forecast was revised upward from 100 billion yen to 105 billion yen, an increase of 11.5% YoY. However, the upward revision figure is at the same level as the consensus, and the surprise is limited. In the midst of uncertainties such as China's future development, the sense of immediate exhaustion is also prevalent.
Eisai<4523>: ¥5830 (-¥798)
Major decline. Regarding the Alzheimer's disease treatment drug 'lecanemab', the evaluation committee of EMA, which judges the new drug approval in the EU, has announced that it has received a negative view. It seems that the negative surprise has increased as the possibility arises that practical use in Europe may be postponed. It seems that the European Medicines Agency (CHMP) believes that the effectiveness of the new drug does not offset the risk of side effects. Although a re-examination is requested, the expectation value for the future performance level is expected to decrease in the short term.
Hitachi Construction Machinery<6305>: ¥3766 (-¥395)
Fell sharply. The first quarter earnings were announced last week, with operating profit of 32.8 billion yen, a 14.0% decrease compared to the same period last year. The progress rate for the full-year plan of 161 billion yen, a 1.0% decrease from the previous period, remains at 20%, and the market consensus is believed to have fallen more than 10 billion yen. The company seems to be generally in line with expectations, but the yen's depreciation is believed to have been supportive, and demand in Asia and Oceania appears to have fallen more than expected. Expectations of an upward trend in performance have declined.
Modalis<4883>: ¥125 (+¥30)
Limit up. It seems that the disclosure of the announcement that he will present the development data of the improved type AAV vector production of MDL-101 at the 16th Bio Process Summit to be held in Boston, USA on the 24th is still well received. Modified capsids are being studied by many groups and are achieving remarkable results, but manufacturing for practical use is still under development. In this conference, the company will present the method and results of manufacturing MDL-101 using muscle-specific modified type AAV vector, which is under development for clinical use.
Solegia<4597>: ¥53 (+¥12)
Surging. On the 26th, Macquarie bank, a leading investment bank, announced that it had submitted a change report (5% rule report) to the Ministry of Finance. Due to the large drop last weekend, buying has become dominant. Macquarie Bank's shareholding ratio decreased from 7.12% to 2.95%. The number of shares held decreased from 15,517,300 shares (including 11,549,900 potential shares) to 6,422,900 shares (including 662,900 potential shares). The reporting obligation date is July 22nd.
Solacom<147A>: ¥1311 (+¥11)
Rebound. After the close of trading on the 26th, it was announced that it had decided to acquire part of Chariot's stock and make it a subsidiary (joint venture). FLECT's 'Cariot' business started in 2016 and has been providing real-time location information for corporate vehicles and DX of vehicle management operations as 'a cloud that connects cars and enterprises and reforms driver workstyles'. The joint venture will start operations formally from October 24th and will provide cutting-edge vehicle management solutions to more companies.